StaveMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.7/10
Best for: compounded semaglutide or tirzepatide from named pharmacies with a no-weight-loss refund
StaveMD's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
StaveMD is the trading name of RZ International LLC, a California company that sells compounded GLP-1s through OpenLoop Health's clinician network and names four dispensing pharmacies. Semaglutide injections start at $179 a month, a dissolving semaglutide tablet at $199 and tirzepatide at $249, with no membership fee. Plans renew every four weeks, and a guarantee refunds every payment if you take the drug as prescribed and lose no weight.
Is StaveMD legit?
Yes. StaveMD is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 7.7/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a StaveMD promo or coupon code?
We know of no promo or coupon code for StaveMD. Its listed price is $179 a month. Coupon sites advertising "StaveMD discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how StaveMD compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to StaveMD
Editorial score · methodology
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
StaveMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- What's included
- Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How StaveMD scores
Six columns, each one computed from something StaveMD has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
5.4/10$179/month is 5% below the $188 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves 51 of 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on StaveMD
Last checked October 2026- Checked the listed price across 3 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for StaveMD
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with StaveMD involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1StaveMD shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask StaveMD which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes shipping.
- Lowest ongoing monthly price: semaglutide $179, tirzepatide $249. That leaves out membership fees, first-month rates and insurance copays.
- StaveMD serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting StaveMD
- Phone
- (855) 597-1248
- StaveMD offers email support
- Hours
- 24/7
Cancelling StaveMD
Taken from the terms StaveMD publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Plans continue every 4 weeks until canceled; 12-month upfront plans are also offered
- Refund policy
- "Once a provider has approved your prescription and your medication has been ordered, that payment is not refundable, except under the StaveMD Weight Loss Guarantee"
- Early-termination fee
- None
GLP-1 medications StaveMD offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Listed as "Starting from $179/mo" with free shipping and no membership fee. Plans renew every four weeks, so there are 13 charges a year; longer plan options are shown only during sign-up.
Listed as "Starting from $199/mo" for compounded semaglutide as a dissolving tablet.
Listed as "Starting from $249/mo" for compounded tirzepatide.
Check the price yourself before you pay
Every figure here was read off StaveMD's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $179 a month, close to the $188 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $249 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes shipping
- Serves all 50 states
- We found no FDA warning letters issued to StaveMD
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What StaveMD charges
StaveMD lists $179/month.
- Compounded semaglutide: $179/month
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $249/month
For compounded semaglutide, the median across the sellers we compare is $188/month, so StaveMD's $179 lands mid-market. Price is unlikely to be the deciding factor.
DudeMeds dispenses semaglutide and tirzepatide from $175/month, which makes it the fair comparison to run before you commit here.
What StaveMD dispenses
StaveMD prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at StaveMD at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
StaveMD tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. We found no FDA warning letters issued to StaveMD. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If StaveMD will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether StaveMD bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
- you need access wherever you live
Our read
StaveMD lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. Bodybuilding Health+ is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
StaveMD's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay StaveMD
Starting at $179 a month. Check today's price, then start the intake.
Where StaveMD is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare StaveMD head to head
The sellers closest to StaveMD on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this StaveMD review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See StaveMD's current pricing
Plans start at $179 a month. Whether you qualify is a clinician's decision, made after your intake.